Viewing Study NCT03574220


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-03-03 @ 6:36 AM
Study NCT ID: NCT03574220
Status: WITHDRAWN
Last Update Posted: 2020-04-07
First Post: 2018-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CASE7516
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators